A peptide selected by biopanning identifies the integrin αvβ6 as a prognostic biomarker for nonsmall cell lung cancer

Anissa N. Elayadi, Kausar N. Samli, Ludmila Prudkin, Ying Horng Liu, Aihua Bian, Xian Jin Xie, Ignacio I. Wistuba, Jack A. Roth, Michael J. McGuire, Kathlynn C. Brown

Research output: Contribution to journalArticle

115 Citations (Scopus)

Abstract

The development of new modes of diagnosis and targeted therapy for lung cancer is dependent on the identification of unique cell surface features on cancer cells and isolation of reagents that bind with high affinity and specificity to these biomarkers. We recently isolated a 20-mer peptide which binds to the lung adenocarcinoma cell line, H2009, from a phage-displayed peptide library. We show here that the cellular receptor for this peptide, TP H2009.1, is the uniquely expressed integrin, αvβ 6, and the peptide binding to lung cancer cell lines correlates to integrin expression. The peptide is able to mediate cell-specific uptake of a fluorescent nanoparticle via this receptor. Expression of α vβ6 was assessed on 311 human lung cancer samples. The expression of this integrin is widespread in early-stage nonsmall cell lung carcinoma (NSCLC). Log-rank test and Cox regression analyses show that expression of this integrin is significantly associated with poor patient outcome. Preferential expression is observed in the tumors compared with the surrounding normal lung tissue. Our data indicate that αvβ 6 is a prognostic biomarker for NSCLC and may serve as a receptor for targeted therapies. Thus, cell-specific peptides isolated from phage biopanning can be used for the discovery of cell surface biomarkers, emphasizing the utility of peptide libraries to probe the surface of a cell.

Original languageEnglish (US)
Pages (from-to)5889-5895
Number of pages7
JournalCancer Research
Volume67
Issue number12
DOIs
StatePublished - Jun 15 2007

Fingerprint

Integrins
Non-Small Cell Lung Carcinoma
Biomarkers
Peptides
Peptide Library
Lung Neoplasms
Bacteriophages
Lung
Thromboxane Receptors
Carcinoma
Cell Line
Peptide Receptors
Cell Separation
Nanoparticles
Neoplasms
Regression Analysis
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A peptide selected by biopanning identifies the integrin αvβ6 as a prognostic biomarker for nonsmall cell lung cancer. / Elayadi, Anissa N.; Samli, Kausar N.; Prudkin, Ludmila; Liu, Ying Horng; Bian, Aihua; Xie, Xian Jin; Wistuba, Ignacio I.; Roth, Jack A.; McGuire, Michael J.; Brown, Kathlynn C.

In: Cancer Research, Vol. 67, No. 12, 15.06.2007, p. 5889-5895.

Research output: Contribution to journalArticle

Elayadi, AN, Samli, KN, Prudkin, L, Liu, YH, Bian, A, Xie, XJ, Wistuba, II, Roth, JA, McGuire, MJ & Brown, KC 2007, 'A peptide selected by biopanning identifies the integrin αvβ6 as a prognostic biomarker for nonsmall cell lung cancer', Cancer Research, vol. 67, no. 12, pp. 5889-5895. https://doi.org/10.1158/0008-5472.CAN-07-0245
Elayadi, Anissa N. ; Samli, Kausar N. ; Prudkin, Ludmila ; Liu, Ying Horng ; Bian, Aihua ; Xie, Xian Jin ; Wistuba, Ignacio I. ; Roth, Jack A. ; McGuire, Michael J. ; Brown, Kathlynn C. / A peptide selected by biopanning identifies the integrin αvβ6 as a prognostic biomarker for nonsmall cell lung cancer. In: Cancer Research. 2007 ; Vol. 67, No. 12. pp. 5889-5895.
@article{3bf70e0d618b4a1da786b4db8da7cae6,
title = "A peptide selected by biopanning identifies the integrin αvβ6 as a prognostic biomarker for nonsmall cell lung cancer",
abstract = "The development of new modes of diagnosis and targeted therapy for lung cancer is dependent on the identification of unique cell surface features on cancer cells and isolation of reagents that bind with high affinity and specificity to these biomarkers. We recently isolated a 20-mer peptide which binds to the lung adenocarcinoma cell line, H2009, from a phage-displayed peptide library. We show here that the cellular receptor for this peptide, TP H2009.1, is the uniquely expressed integrin, αvβ 6, and the peptide binding to lung cancer cell lines correlates to integrin expression. The peptide is able to mediate cell-specific uptake of a fluorescent nanoparticle via this receptor. Expression of α vβ6 was assessed on 311 human lung cancer samples. The expression of this integrin is widespread in early-stage nonsmall cell lung carcinoma (NSCLC). Log-rank test and Cox regression analyses show that expression of this integrin is significantly associated with poor patient outcome. Preferential expression is observed in the tumors compared with the surrounding normal lung tissue. Our data indicate that αvβ 6 is a prognostic biomarker for NSCLC and may serve as a receptor for targeted therapies. Thus, cell-specific peptides isolated from phage biopanning can be used for the discovery of cell surface biomarkers, emphasizing the utility of peptide libraries to probe the surface of a cell.",
author = "Elayadi, {Anissa N.} and Samli, {Kausar N.} and Ludmila Prudkin and Liu, {Ying Horng} and Aihua Bian and Xie, {Xian Jin} and Wistuba, {Ignacio I.} and Roth, {Jack A.} and McGuire, {Michael J.} and Brown, {Kathlynn C.}",
year = "2007",
month = "6",
day = "15",
doi = "10.1158/0008-5472.CAN-07-0245",
language = "English (US)",
volume = "67",
pages = "5889--5895",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - A peptide selected by biopanning identifies the integrin αvβ6 as a prognostic biomarker for nonsmall cell lung cancer

AU - Elayadi, Anissa N.

AU - Samli, Kausar N.

AU - Prudkin, Ludmila

AU - Liu, Ying Horng

AU - Bian, Aihua

AU - Xie, Xian Jin

AU - Wistuba, Ignacio I.

AU - Roth, Jack A.

AU - McGuire, Michael J.

AU - Brown, Kathlynn C.

PY - 2007/6/15

Y1 - 2007/6/15

N2 - The development of new modes of diagnosis and targeted therapy for lung cancer is dependent on the identification of unique cell surface features on cancer cells and isolation of reagents that bind with high affinity and specificity to these biomarkers. We recently isolated a 20-mer peptide which binds to the lung adenocarcinoma cell line, H2009, from a phage-displayed peptide library. We show here that the cellular receptor for this peptide, TP H2009.1, is the uniquely expressed integrin, αvβ 6, and the peptide binding to lung cancer cell lines correlates to integrin expression. The peptide is able to mediate cell-specific uptake of a fluorescent nanoparticle via this receptor. Expression of α vβ6 was assessed on 311 human lung cancer samples. The expression of this integrin is widespread in early-stage nonsmall cell lung carcinoma (NSCLC). Log-rank test and Cox regression analyses show that expression of this integrin is significantly associated with poor patient outcome. Preferential expression is observed in the tumors compared with the surrounding normal lung tissue. Our data indicate that αvβ 6 is a prognostic biomarker for NSCLC and may serve as a receptor for targeted therapies. Thus, cell-specific peptides isolated from phage biopanning can be used for the discovery of cell surface biomarkers, emphasizing the utility of peptide libraries to probe the surface of a cell.

AB - The development of new modes of diagnosis and targeted therapy for lung cancer is dependent on the identification of unique cell surface features on cancer cells and isolation of reagents that bind with high affinity and specificity to these biomarkers. We recently isolated a 20-mer peptide which binds to the lung adenocarcinoma cell line, H2009, from a phage-displayed peptide library. We show here that the cellular receptor for this peptide, TP H2009.1, is the uniquely expressed integrin, αvβ 6, and the peptide binding to lung cancer cell lines correlates to integrin expression. The peptide is able to mediate cell-specific uptake of a fluorescent nanoparticle via this receptor. Expression of α vβ6 was assessed on 311 human lung cancer samples. The expression of this integrin is widespread in early-stage nonsmall cell lung carcinoma (NSCLC). Log-rank test and Cox regression analyses show that expression of this integrin is significantly associated with poor patient outcome. Preferential expression is observed in the tumors compared with the surrounding normal lung tissue. Our data indicate that αvβ 6 is a prognostic biomarker for NSCLC and may serve as a receptor for targeted therapies. Thus, cell-specific peptides isolated from phage biopanning can be used for the discovery of cell surface biomarkers, emphasizing the utility of peptide libraries to probe the surface of a cell.

UR - http://www.scopus.com/inward/record.url?scp=34250862163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250862163&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-07-0245

DO - 10.1158/0008-5472.CAN-07-0245

M3 - Article

VL - 67

SP - 5889

EP - 5895

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 12

ER -